DMARDs (synthetic)

Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis
Laura Pirilä, Tuulikki Sokka, Markku J Kauppi, Vappu M Rantalaiho, Eero Mervaala, Kari Puolakka

Annals of the Rheumatic Diseases Dec 2017, 76 (12) e49; DOI: 10.1136/annrheumdis-2017-211505
Response to: ‘The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis’ by Pirilä et al
Josef S Smolen, Robert B M Landewé, Désirée van der Heijde

Annals of the Rheumatic Diseases Dec 2017, 76 (12) e50; DOI: 10.1136/annrheumdis-2017-211524
HLA-A 31:01 is not associated with the development of methotrexate pneumonitis in the UK population: results from a genome-wide association study
James Bluett, Sally-Ann Owen, Jonathan Massey, Ana Alfirevic, Munir Pirmohamed, Darren Plant, Suzanne M M Verstappen, Anne Barton

Annals of the Rheumatic Diseases Dec 2017, 76 (12) e51; DOI: 10.1136/annrheumdis-2017-211512
Response to: ‘2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?’ by Misra et al
Josef S Smolen, Robert B M Landewé, Désirée van der Heijde

Annals of the Rheumatic Diseases Nov 2017, 76 (11) e48; DOI: 10.1136/annrheumdis-2017-211455
2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
Durga Prasanna Misra, Vikas Agarwal, Aman Sharma, Anupam Wakhlu, Vir Singh Negi

Annals of the Rheumatic Diseases Nov 2017, 76 (11) e47; DOI: 10.1136/annrheumdis-2017-211446
Statin therapy now more common than steroids in clinical practice
Anil Pareek, Nitin Chandurkar

Annals of the Rheumatic Diseases Jul 2017, 76 (7) e18; DOI: 10.1136/annrheumdis-2016-210858
Response to: ‘Statin therapy now more common than steroids in clinical practice’ by Pareek and Chankurdar
Gulsen Ozen, Sofia Pedro, Kaleb Michaud

Annals of the Rheumatic Diseases Jul 2017, 76 (7) e19; DOI: 10.1136/annrheumdis-2016-210906
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis
Sofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, Jackie L Nam, Josef S Smolen, Désirée van der Heijde, Maxime Dougados, Ronald van Vollenhoven, Johannes W Bijlsma, Gerd R Burmester, Marieke Scholte-Voshaar, Louise Falzon, Robert B M Landewé

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 1101-1136; DOI: 10.1136/annrheumdis-2016-210708
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
Katerina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, Sofia Ramiro, Josef Smolen, Désirée van der Heijde, Maxime Dougados, Johannes Bijlsma, Gerd Burmester, Marieke Scholte, Ronald van Vollenhoven, Robert Landewé

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 1102-1107; DOI: 10.1136/annrheumdis-2016-210711
EULAR recommendations for disease management: guidance not guidelines
David S Pisetsky

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 935-938; DOI: 10.1136/annrheumdis-2016-211005

Main menu

DMARDs (synthetic)

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DMARDs (synthetic)

Pages